Product Image

Ginkgo Biloba Extract 120 mg

The Vitamin Shoppe
4.8
★ ★ ★ ★ ★
(86 ratings)
Ginkgo
Product Image
Score76
A useful full-serving ginkgo extract for circulation-focused cognitive support. Incomplete marker percentages limit confidence in exact potency.
How scoring works
Quantity:120 Capsule(s) • (120 servings)
Goals:
Cognitive Support
Mental Focus
Brain Health
Productivity Boost

Score 76

A useful full-serving ginkgo extract for circulation-focused cognitive support. Incomplete marker percentages limit confidence in exact potency.
How scoring works
$21.99($0.18 per serving)
iHerb
$ 21.99
Report prices

Analysis

The capsule supplies 120 mg of extract, a useful amount for regular ginkgo supplementation. Flavonol glycosides and terpene lactones are named, though their percentages are not listed.

Ginkgo may support cerebral circulation, memory, and attention in selected users, with less certainty for immediate productivity in healthy adults. Its vision role is limited to possible ocular blood-flow support rather than direct macular nutrition.

The single-ingredient design is focused and avoids underdosed add-ons. Users seeking broader support for stress, cognitive energy, or retinal structure will need other ingredients.

Who is it for
  • Adults seeking a full-serving ginkgo capsule
  • People focused on memory or attention support
  • Users who prefer single-ingredient formulas
Best for
  • Cerebral-circulation support
  • Sustained cognitive routines
  • Adding ginkgo to a broader nootropic plan

Pros

  • Provides a commonly used extract amount
  • Names both major marker groups
  • Simple focused formula

Cons

  • Marker percentages are missing
  • No ginkgolic-acid purity limit
  • Narrower than a multi-pathway cognitive product

Warnings

  • Ginkgo may increase bleeding risk with anticoagulants or antiplatelet medicines.
  • Ginkgo use around surgery should be reviewed with the surgical team.
  • Headache, dizziness, or digestive discomfort may occur.

Nutrient quality

83 Highest impact

The key ginkgo marker groups are named, but their percentages and a purity limit are not fully disclosed. The formula supplies a full target-range extract amount, with no obvious overdosing.

.

Ingredient transparency

80 High impact

The main active amounts are clearly listed, and no proprietary blend hides them. Intake directions, non-active ingredients, and some extract-quality details are absent from the supplied data.

.

Customer satisfaction

62 Moderate impact

The supplied average is very strong and the response volume is limited. No detailed feedback is provided to assess recurring complaints or fit with the intended purpose.

.

Value for money

76 High impact

The serving cost is appealing, but incomplete extract verification limits confidence in value. A fully standardized extract would provide a more dependable comparison.

.
Report analysis

Goals

Cognitive Support
Impact
High effect
B+ Goal FitB- Strength of SupportC- CoverageA Formula Quality

Ginkgo directly targets cerebral circulation and memory support at a useful extract amount. The single-ingredient formula is narrow but provides clear depth in its chosen pathway.

Flavonol glycosides and terpene lactones are named, yet their percentages are not disclosed. Ginkgo may increase bleeding risk when combined with anticoagulant or antiplatelet medicines.

Study evidence
Ginkgo Supportive 87 studies
Impact
High effect
B Goal FitB- Strength of SupportC- CoverageA Formula Quality

Ginkgo directly supports cerebral circulation and attention, giving the product a clear focus role. The standalone format does not address stress resilience, cognitive energy, or neurotransmitter precursors.

The 120 mg extract amount falls within an effective daily range, but active-marker percentages are not stated. Ginkgo may increase bleeding risk when combined with anticoagulant or antiplatelet medicines.

Study evidence
Ginkgo Supportive 28 studies
Brain Health
Impact
High effect
C+ Goal FitC Strength of SupportD+ CoverageB+ Formula Quality

The focused Ginkgo formula may support cerebral circulation and cognition in selected users. Its disclosed extract amount falls within a commonly used daily range.

Flavonol glycosides and terpene lactones are named without percentages, preventing confirmation of standardization. Ginkgo can raise bleeding risk when combined with anticoagulant or antiplatelet medicines.

Study evidence
Ginkgo Supportive 90 studies
Productivity Boost
Impact
High effect
C- Goal FitC+ Strength of SupportD CoverageA+ Formula Quality

Ginkgo may modestly support processing and mental clarity through cerebral circulation, but it is not a reliable acute productivity aid. The extract amount reaches a commonly used range, while human results for healthy-user focus remain mixed.

Active-marker classes are named, but their percentages are missing and prevent confirmation of standardized potency. Ginkgo may increase bleeding risk when combined with anticoagulant or antiplatelet medicines.

Study evidence
Ginkgo Supportive 20 studies
Ginkgo Supportive 12 studies
Impact
Moderate effect
D- Goal FitC- Strength of SupportD- CoverageB Formula Quality

Ginkgo may support ocular circulation, but it does not supply the carotenoids, antioxidants, or structural fats central to vision nutrition. Evidence for eye outcomes is limited and less direct than established macular-pigment research.

The extract amount is meaningful, but flavonol-glycoside and terpene-lactone percentages are missing. Ginkgo may increase bleeding risk when combined with anticoagulant or antiplatelet medicines.

Study evidence
Ginkgo Supportive 11 studies

Ingredients

IngredientAmount per serving
Ginkgo biloba extract (Ginkgo Flavonol Glycosides, Terpene Lactones)
120 mg
Gluten Free Adults 18–50 Dairy Free Sugar Free
Report overview
F Active Ingredient Quality & BioavailabilityA+ Dose, Safety & Label TransparencyF Value
Flavone glycoside and terpene lactone markers are named, but their percentages are not stated. 120 mg falls within the effective daily extract range. Missing marker percentages prevent a reliable standardized-dose cost comparison. Ginkgo may increase bleeding risk when combined with anticoagulant or antiplatelet medicines.
Loading alternative details
Report alternatives

Sources

Published studies used for the product analysis and the top-ranked studies for each ingredient and goal.

  1. Efficacy and adverse effects of ginkgo biloba for cognitive impairment and dementia: a systematic review and meta-analysis.
    Tan MS; Yu JT; Tan CC; Wang HF; Meng XF; Wang C; Jiang T; Zhu XC; Tan L · Journal of Alzheimer's disease : JAD · 2015
    Meta-analysis2,561 participants9 studies pooledBrain Health forGinkgo
  2. Ginkgo for elderly people with dementia and age-associated memory impairment: a randomized clinical trial.
    van Dongen M; van Rossum E; Kessels A; Sielhorst H; Knipschild P · Journal of clinical epidemiology · 2003
    Randomized trial214 participantsBrain Health forGinkgo
  3. Ginkgo biloba for cognitive impairment and dementia.
    Wieland LS; Ludeman E; Chi Y; Feinberg TM; Chen IH; Chen KH; Zhu Y; Wolverson E; Amri H · The Cochrane database of systematic reviews · 2026
    Meta-analysis10,613 participants82 studies pooledBrain Health Cognitive Support Productivity Boost forGinkgo
  4. Ginkgo biloba Extract EGb 761 in the Treatment of Patients with Mild Neurocognitive Impairment: A Systematic Review.
    Hort J; Duning T; Hoerr R · Neuropsychiatric disease and treatment · 2023
    Systematic review946 participants9 studies pooledMental Focus forGinkgo
  5. Is Ginkgo biloba a cognitive enhancer in healthy individuals? A meta-analysis.
    Laws KR; Sweetnam H; Kondel TK · Human psychopharmacology · 2014
    Meta-analysis1,132 participants13 studies pooledMental Focus forGinkgo
  6. Ginkgo biloba: no robust effect on cognitive abilities or mood in healthy young or older adults.
    Burns NR; Bryan J; Nettelbeck T · Human psychopharmacology · 2006
    Randomized trial197 participantsMental Focus forGinkgo
  7. Ginkgo biloba extract EGb 761 is safe and effective in the treatment of mild dementia - a meta-analysis of patient subgroups in randomised controlled trials.
    Riepe M; Hoerr R; Schlaefke S · The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry · 2025
    Meta-analysis782 participants4 studies pooledProductivity Boost Brain Health forGinkgo
  8. Effects of Ginkgo biloba on alertness and chemosensory function in healthy adults.
    Mattes RD; Pawlik MK · Human psychopharmacology · 2004
    Randomized trial39 participantsProductivity Boost forGinkgo
  9. Effect of Ginkgo biloba extracts in the prevention of posterior capsule opacification after cataract surgery: A randomized clinical trial.
    Amiri AA; Jafari R; Amiri AA; Rad HA; Daneshvar F; Charati JY; Amiri AA · Oman journal of ophthalmology · 2025
    Randomized trial144 participantsVision Support forGinkgo
  10. Ginkgo biloba--an appraisal.
    Dubey AK; Shankar PR; Upadhyaya D; Deshpande VY · Kathmandu University medical journal (KUMJ) · 2007
    Narrative reviewVision Support forGinkgo
  11. Electrophysiological analysis of the effects of ginkgo biloba on visual processing in older healthy adults.
    Page JW; Findley J; Crognale MA · The journals of gerontology. Series A, Biological sciences and medical sciences · 2006
    Clinical trialVision Support forGinkgo
  12. Efficacy of Ginkgo biloba extract EGb 761® in dementia with behavioural and psychological symptoms: A systematic review.
    von Gunten A; Schlaefke S; Überla K · The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry · 2017
    Meta-analysis1,628 participants4 studies pooledCognitive Support Brain Health forGinkgo
  13. Ginkgo biloba Extract (EGb761), Cholinesterase Inhibitors, and Memantine for the Treatment of Mild-to-Moderate Alzheimer's Disease: A Network Meta-Analysis.
    Thancharoen O; Limwattananon C; Waleekhachonloet O; Rattanachotphanit T; Limwattananon P; Limpawattana P · Drugs & aging · 2019
    Meta-analysisCognitive Support forGinkgo
  14. Ginkgo biloba extract EGb 761® improves cognition and overall condition after ischemic stroke: Results from a pilot randomized trial.
    Cui M; You T; Zhao Y; Liu R; Guan Y; Liu J; Liu X; Wang X; Dong Q · Frontiers in pharmacology · 2023
    Randomized trial201 participantsBrain Health Productivity Boost forGinkgo
  15. Ginkgo biloba extract EGb 761® in dementia with neuropsychiatric features: a randomised, placebo-controlled trial to confirm the efficacy and safety of a daily dose of 240 mg.
    Herrschaft H; Nacu A; Likhachev S; Sholomov I; Hoerr R; Schlaefke S · Journal of psychiatric research · 2012
    Randomized trial410 participantsBrain Health forGinkgo
  16. Efficacy of ginkgo diterpene lactone meglumine on cognitive function in patients with acute ischemic stroke: a predefined exploratory analysis of a multicenter, double-blind, randomized controlled trial.
    Tian X; Xu Q; Xia X; Zhang Y; Meng X; Wang A · Journal of neurology · 2024
    Randomized trial3,163 participantsCognitive Support forGinkgo
  17. A placebo-controlled, double-blind, randomized trial of an extract of Ginkgo biloba for dementia. North American EGb Study Group.
    Le Bars PL; Katz MM; Berman N; Itil TM; Freedman AM; Schatzberg AF · JAMA · 1997
    Randomized trial309 participantsCognitive Support Productivity Boost forGinkgo
  18. Alleviating neuropsychiatric symptoms in dementia: the effects of Ginkgo biloba extract EGb 761. Findings from a randomized controlled trial.
    Bachinskaya N; Hoerr R; Ihl R · Neuropsychiatric disease and treatment · 2011
    Randomized trial410 participantsCognitive Support forGinkgo
  19. Efficacy and safety of a once-daily formulation of Ginkgo biloba extract EGb 761 in dementia with neuropsychiatric features: a randomized controlled trial.
    Ihl R; Bachinskaya N; Korczyn AD; Vakhapova V; Tribanek M; Hoerr R; Napryeyenko O; GOTADAY Study Group · International journal of geriatric psychiatry · 2013
    Randomized trial410 participantsCognitive Support forGinkgo
  20. Proof of efficacy of the Ginkgo biloba special extract EGb 761 in outpatients suffering from mild to moderate primary degenerative dementia of the Alzheimer type or multi-infarct dementia.
    Kanowski S; Herrmann WM; Stephan K; Wierich W; Hörr R · Phytomedicine : international journal of phytotherapy and phytopharmacology · 2012
    Randomized trial216 participantsMental Focus forGinkgo
  21. Proof of efficacy of the ginkgo biloba special extract EGb 761 in outpatients suffering from mild to moderate primary degenerative dementia of the Alzheimer type or multi-infarct dementia.
    Kanowski S; Herrmann WM; Stephan K; Wierich W; Hörr R · Pharmacopsychiatry · 1996
    Randomized trial216 participantsMental Focus forGinkgo
  22. Ginkgo biloba extract improved cognitive and neurological functions of acute ischaemic stroke: a randomised controlled trial.
    Li S; Zhang X; Fang Q; Zhou J; Zhang M; Wang H; Chen Y; Xu B; Wu Y; Qian L; Xu Y · Stroke and vascular neurology · 2021
    Randomized trial348 participantsMental Focus forGinkgo
  23. Ginkgo biloba in the Aging Process: A Narrative Review.
    Barbalho SM; Direito R; Laurindo LF; Marton LT; Guiguer EL; Goulart RA; Tofano RJ; Carvalho ACA; Flato UAP; Capelluppi Tofano VA; Detregiachi CRP; Bueno PCS; Girio RSJ; Araújo AC · Antioxidants (Basel, Switzerland) · 2024
    Narrative review14 studies pooledMental Focus forGinkgo
  24. [Ginkgo biloba extract EGb 761 in the treatment of dementia: evidence of efficacy and tolerability].
    Kasper S; Schubert H · Fortschritte der Neurologie-Psychiatrie · 2009
    Meta-analysis10 studies pooledProductivity Boost forGinkgo
  25. Dietary Flavonoids and Human Cognition: A Meta-Analysis.
    Cheng N; Bell L; Lamport DJ; Williams CM · Molecular nutrition & food research · 2022
    Meta-analysis5,519 participants80 studies pooledProductivity Boost forGinkgo
  26. Limited cognitive benefits in Stage +2 postmenopausal women after 6 weeks of treatment with Ginkgo biloba.
    Elsabagh S; Hartley DE; File SE · Journal of psychopharmacology (Oxford, England) · 2005
    Randomized trial87 participantsProductivity Boost forGinkgo
  27. Efficacy and safety of Ginkgo biloba extract EGb 761 in mild cognitive impairment with neuropsychiatric symptoms: a randomized, placebo-controlled, double-blind, multi-center trial.
    Gavrilova SI; Preuss UW; Wong JW; Hoerr R; Kaschel R; Bachinskaya N; GIMCIPlus Study Group · International journal of geriatric psychiatry · 2015
    Randomized trial160 participantsProductivity Boost forGinkgo
  28. Modulation of cognitive performance following single doses of 120 mg Ginkgo biloba extract administered to healthy young volunteers.
    Kennedy DO; Jackson PA; Haskell CF; Scholey AB · Human psychopharmacology · 2008
    Randomized trial78 participantsProductivity Boost forGinkgo
  29. Effect of Ginkgo biloba extract on preexisting visual field damage in normal tension glaucoma.
    Quaranta L; Bettelli S; Uva MG; Semeraro F; Turano R; Gandolfo E · Ophthalmology · 2003
    Randomized trial27 participantsVision Support forGinkgo
  30. [Ginkgo extract in impaired vision--treatment with special extract EGb 761 of impaired vision due to dry senile macular degeneration].
    Fies P; Dienel A · Wiener medizinische Wochenschrift (1946) · 2002
    Randomized trial99 participantsVision Support forGinkgo
  31. Short-term effects of Ginkgo biloba extract on peripapillary retinal blood flow in normal tension glaucoma.
    Park JW; Kwon HJ; Chung WS; Kim CY; Seong GJ · Korean journal of ophthalmology : KJO · 2012
    Randomized trial30 participantsVision Support forGinkgo
  32. [The course of color vision in early diabetic retinopathy treated with Ginkgo biloba extract. A preliminary double-blind versus placebo study].
    Lanthony P; Cosson JP · Journal francais d'ophtalmologie · 1989
    Randomized trial29 participantsVision Support forGinkgo